home All News open_in_new Full Article

Keensight encarga a Moelis el proceso de venta de 3P Biovian

El fondo de capital riesgo francés prepara su desinversión en el CDMO biotecnológico, que se valora en más de 300 millones. Leer


today 4 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3543807915
Add Watch Country

arrow_drop_down